Pfizer’s RSV Vaccine for Pregnant Women Wins FDA Panel Support
TimeMAY 2023
Though vaccines are what we're truly waiting for, this approval is a major step toward protecting children against the growing threat of RSV. As this antibody treatment will be different from the rollout of traditional childhood vaccines, the FDA and CDC are also being very cautious so as to not rush anything out prematurely. This has been a painstaking accomplishment.
Under the current US health bureaucracy, approval of some treatments such as therapeutics takes far longer than vaccines. The FDA's glacial pace for delivery of these treatments must be improved. Red tape is costing the US lives.